Epsilon Imaging, Inc. Release: Study Demonstrates Improved Monitoring of Patients at Risk for Cardiotoxicity Using EchoInsight® for Cardio Oncology
7/1/2013 11:14:28 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MINNEAPOLIS--(BUSINESS WIRE)--Epsilon Imaging, Inc., a visualization and analysis software provider transforming cardiac diagnostic workflow, today announced a study demonstrating EchoInsight for Cardio Oncology to be a high quality, efficient application for comprehensive assessment of LV function. The study, being presented at the ASE 2013 Scientific Sessions in Minneapolis, MN, further indicated EchoInsight for Cardio Oncology facilitates monitoring of patients at risk for cardiotoxicity. EchoInsight for Cardio Oncology is a vendor neutral application designed to assist clinicians in improving confidence and workflow of study interpretation and reporting when monitoring oncology patients. The Company is showcasing EchoInsight and its suite of applications at the conference (booth 522).
Help employers find you! Check out all the jobs and post your resume.
comments powered by